Mark E Burkard Selected Research

Mark E Burkard Research Topics

Disease

30	Neoplasms (Cancer) 07/2023 - 12/2010
20	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2012
5	Chromosomal Instability (Chromosome Stability) 10/2023 - 11/2020
3	Triple Negative Breast Neoplasms 12/2021 - 01/2016
2	Adenocarcinoma 01/2024 - 01/2024
2	Lung Neoplasms (Lung Cancer) 02/2023 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2023
1	Microsatellite Instability 02/2023
1	Bites and Stings (Sting) 12/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2020
1	Diarrhea 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Hyponatremia 01/2020
1	medullary Thyroid cancer 01/2020
1	Melanoma (Melanoma, Malignant) 01/2018
1	Exanthema (Rash) 12/2017
1	Pathologic Complete Response 11/2017
1	Hot Flashes 01/2017
1	Pain (Aches) 01/2017
1	Nausea 01/2017
1	Hypokalemia 01/2017
1	Myalgia 01/2017
1	Polyploidy 01/2016
1	Fever (Fevers) 01/2012

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2020
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 03/2014
3	cabozantinibIBA 01/2023 - 01/2020
3	Hormones (Hormone)IBA 10/2021 - 07/2012
3	RNA (Ribonucleic Acid)IBA 02/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 02/2023 - 12/2021
2	CrizotinibIBA 01/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Taxoids (Taxanes)IBA 12/2021 - 09/2021
2	Aromatase InhibitorsIBA 10/2021 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
2	Estrogens (Estrogen)FDA Link 11/2017 - 01/2017
2	MK 2206IBA 11/2017 - 01/2016
1	PoisonsIBA 10/2023
1	pembrolizumabIBA 02/2023
1	Aurora Kinase BIBA 01/2022
1	Immune Checkpoint ProteinsIBA 12/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2021
1	eribulin FDA Link 12/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2021
1	entinostat (MS 275)IBA 10/2021
1	exemestane (Aromasin)FDA Link 10/2021
1	human ERBB2 proteinIBA 10/2021
1	Histone Deacetylase InhibitorsIBA 10/2021
1	taxaneIBA 09/2021
1	Small Cytoplasmic RNAIBA 02/2021
1	theasinensin AIBA 01/2021
1	InterferonsIBA 11/2020
1	vandetanib (ZD6474)IBA 01/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	pericentrinIBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	AntibodiesIBA 01/2020
1	selpercatinibIBA 01/2020
1	dactolisibIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Everolimus FDA Link 01/2019
1	sapanisertibIBA 01/2019
1	centrinone-BIBA 01/2018
1	SteroidsIBA 12/2017
1	Capecitabine (Xeloda)FDA Link 12/2017
1	Fluorouracil (Carac)FDA LinkGeneric 12/2017
1	ProdrugsIBA 12/2017
1	Sunscreening Agents (Sunscreens)IBA 12/2017
1	Estrogen ReceptorsIBA 11/2017
1	Prednisone (Sone)FDA LinkGeneric 11/2017
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2017
1	Goserelin (Zoladex)FDA Link 11/2017
1	AndrogensIBA 01/2017
1	Anaphase-Promoting Complex-CyclosomeIBA 01/2017
1	orteronelIBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	AntimetabolitesIBA 01/2016
1	QuinoxalinesIBA 01/2016
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2016
1	Carcinoembryonic AntigenIBA 01/2016
1	Lapatinib (GW572016)FDA Link 01/2016
1	Estrogen Receptor betaIBA 01/2016
1	AzaguanineIBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2014
1	Docetaxel (Taxotere)FDA Link 06/2014
1	CalciumIBA 07/2012
1	Polo-Like Kinase 1IBA 06/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2012

Therapy/Procedure

15	Therapeutics 03/2024 - 12/2010
8	Drug Therapy (Chemotherapy) 01/2023 - 01/2012
5	Immunotherapy 03/2024 - 03/2021
3	Precision Medicine 07/2023 - 01/2017
2	Pancreatectomy 01/2024 - 01/2024
1	Neoadjuvant Therapy 08/2023
1	Adjuvant Chemotherapy 01/2014